최신 뉴스 — ARKG
ARK Genomic Revolution ETF — 이 펀드를 언급한 주요 언론 기사로, 최신순으로 정렬됩니다. 각 항목을 클릭하면 원본 게시자 페이지로 이동합니다.
최근 7일간 이 펀드를 언급한 기사가 없습니다. 실제 링크가 있는 기사만 표시하며, 빈 자리를 채우지 않습니다. 시장 뉴스 전체 보기 →
관련 데이터 브리핑: ARKG 자체 제작
ARKG jumps 4.27% on August 25, now up 65.72% YTD
ARK Genomic Revolution ETF (ARKG) advanced 4.27% to $50.06 on August 25, with AUM of approximately $1.6 billion. The fund has now gained 65.72% year-to-date, making the day's move incremental relative to a strong broader run. ARKG is an actively managed ETF focused on companies involved in genomics, gene editing, and related biotechnology.
ETF Explorer · Aug 25ARKG rises 10.46% on August 19, up 49.15% YTD
ARK Genomic Revolution ETF closed at $47.73 on August 19, gaining 10.46% on the day, with AUM of approximately $1.56 billion. The fund tracks genomics and biotechnology equities. The single-day move extends a year-to-date gain of 49.15%, making it one of the stronger performers in the thematic equity space in 2025.
ETF Explorer · Aug 19